Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2021 Biotech Stock Picking Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (221)	10/12/2021 5:08:03 PM
From: technetium	Read Replies (1) \| Respond to of 307

I doubt the company had to rely on the FOIA to get the report. foia.gov Agency mission The Department of Health and Human Services (HHS) is the United States government´s principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves. Average processing time for 2020 17 working days for simple requests 154 working days for complex requests

To: DewDiligence_on_SI who wrote (221)	10/13/2021 12:56:19 PM
From: technetium	Read Replies (1) \| Respond to of 307

CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products \| COVID-19 [CDER does seem to have a say in Covid…] “ To promote public confidence in FDA’s scientific review process and in ultimately appropriately using products authorized for emergency use, CDER is disclosing information from our scientific review documents supporting Emergency Use Authorizations (EUA) for drug and biological therapeutic products as appropriate and consistent with our longstanding practice of posting scientific reviews after new drug and biological product approvals. Certain information may be redacted that is exempt from disclosure un2er the Freedom of Information Act (FOIA), 5 U.S.C. sec. 552, such as trade secrets or other information identified by the EUA requestors that is exempt under FOIA. The redacted information may vary depending on the type of data contained in the reviews and whether the requestor consents to the release of information that is exempt under FOIA.” fda.gov